Order Article Reprints

Aquila G, Re Cecconi AD, Forti M, Frapolli R, Bello E, Novelli D, Russo I, Licandro SA, Staszewsky L, Martinelli GB, et al. Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia. Cancers. 2020; 12(8):2312. https://doi.org/10.3390/cancers12082312

Aquila, Giorgio, Andrea David Re Cecconi, Mara Forti, Roberta Frapolli, Ezia Bello, Deborah Novelli, Ilaria Russo, Simonetta Andrea Licandro, Lidia Staszewsky, Giulia Benedetta Martinelli, and et al. 2020. "Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia" Cancers 12, no. 8: 2312. https://doi.org/10.3390/cancers12082312

Aquila, G., Re Cecconi, A. D., Forti, M., Frapolli, R., Bello, E., Novelli, D., Russo, I., Licandro, S. A., Staszewsky, L., Martinelli, G. B., Talamini, L., Pasetto, L., Resovi, A., Giavazzi, R., Scanziani, E., Careccia, G., Vénéreau, E., Masson, S., Latini, R., ... Piccirillo, R. (2020). Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia. Cancers, 12(8), 2312. https://doi.org/10.3390/cancers12082312